General Info Flashcards
(46 cards)
Na+ Normal Lab Value
135-145
K+ Normal Lab Value
3.5-5
BUN Normal Lab Value
7-18
Creatinine Normal Lab Value
0.6-1.2
WBC Normal Lab Value
5,000-10,000
Hemoglobin Normal Lab Value
male 14-18
female 12-16
Hematocrit Normal Lab Value
male 40-52%
female 37-47%
Exceeding the renal threshold
blood glucose of 180-200mg/dL
Diagnostic criteria for diabetes
Hemoglobin A1c > 6.5%
Fasting blood glucose >/= 126 mg/dL on two occasions
Random blood glucose >/= 200 mg/dL with symptoms
Pre-diabetes criteria
Fasting blood glucose of 100 to 125 mg/dL
Hemoglobin A1c greater than 5.7% (to 6.4%)
Rapid-acting insulins
Lispro (Humalog)
Aspart (Novolog)
Human (Afrezza) inhaled
Short-acting insulins
Regular (Humulin-R and Novolin-R)
Intermediate-acting insulins
NPH (Humulin-N and Novolin-N)
Long-acting insulins
Glargine (Lantus)
Detemir (Levemir)
Rapid-acting: Onset, Peak, Duration
Onset: 10-15 min
Peak: 1 hour
Duration: 3-5 hours
Short-acting: Onset, Peak, Duration
Onset: 10-60 min
Peak: 2-3 hours
Duration: 4-6 hours
Intermediate-acting: Onset, Peak, Duration
Onset: 2-4 hours
Peak: 6-8 hours
Duration: 12-16 hours
Long-acting: Onset, Peak, Duration
Onset: 2 hours
Peak: none
Duration: 24 hours
Dawn phenomenon
Relatively normal blood glucose level until approximately 3am, when blood glucose levels begin to rise. (Thought to result from nocturnal surges in growth hormone secretions, which create a greater need for insulin in the early morning hours in patients with type 1 diabetes.)
Somogyi effect
Normal or elevated blood glucose at bedtime, a decrease at 2 to 3am to hypoglycemic levels, and a subsequent increase caused by the production of counter regulatory hormones.
Oral diabetic medications
Bigaunides: Metformin
Sulfonylureas:
2nd- Glipizide, Gluburide, Glimepiride
1st- Chlorpropamide, Tolazamide, Tolbutamide (not used)
Nonsulfonylurea Insulin Secretagogues: Repaglinide, Neteglide
Thiazolidinediones (TZDs): Pioglitazone, Rosiglitazone
Alpha-Glucosidase Inhibitors: Acarbose, Miglitol
Dopamine Agonists: Brocriptine
SGLT2 Inhibitors: Camagliflozin, Dapagliflozin
DDP4 Inhibitors/Incretin Enhancers: Sitagliptin, Saxaglipton, Exenatide
Biguanides
no hypoglycemia
Action: Does NOT stimulate insulin release- decreases liver glucose release and cellular insulin resistance, which makes blood sugar go down.
Contraindication: renal/liver disease, alcoholism, severe CHF, over 80, with contrast dye or anesthesia
AE: muscle cramps (lactic acidosis), N/V, diarrhea.
Sulfonylureas
yes hypoglycemia
Action: Directly stimulates beta cells of pancreas to secrete insulin and improve insulin action at the cellular level
Contraindication: alcohol (causes severe N/V), sulfa allergy
AE: hypoglycemia, nausea, heartburn, weight gain
Thiazolidinediones (TZDs)
no hypoglycemia
Action: Enhances insulin action and glucose utilization in peripheral tissues
Contraindication: Liver failure (monitor before starting and periodically)
AE: impair liver function, reduce effectiveness of contraceptives, cause MI/HF (hyperlipidemia), anemia, impaired platelet function, weight gain, edema